Clinical trial research in focus: overcoming barriers in MDR-TB clinical trials

Lancet Respir Med. 2017 Apr;5(4):247-248. doi: 10.1016/S2213-2600(17)30091-7.

Authors

Alimuddin Zumla¹, Ibrahim Abubakar²

Affiliations

¹ Division of Infection and Immunity, University College London and NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, UK.
² Institute for Global Health, University College London, London, UK. Electronic address: i.abubakar@ucl.ac.uk.

PMID: 28353422
DOI: 10.1016/S2213-2600(17)30091-7

No abstract available

MeSH terms

Adult
Antitubercular Agents / economics
Antitubercular Agents / therapeutic use*
Biomedical Research / standards*
Child
Female
Global Health
Humans
Male
Randomized Controlled Trials as Topic
Research Design
Tuberculosis, Multidrug-Resistant / drug therapy*

Substances

Antitubercular Agents